Association of oestrogen-receptor gene (ESR1) polymorphisms with migraine in the large Norfolk Island pedigree

Cephalalgia

Volumn 33, Issue 14, 2013, Pages 1139-1147

  Rodriguez Acevedo, Astrid J ^a   Maher, Bridget H ^a   Lea, Rodney A ^a   Benton, Miles ^a   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

ESR1; haplotype analysis; hormone receptor genes; Migraine; PGR

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MOLECULAR MARKER; PROGESTERONE RECEPTOR;

ARTICLE; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NORFOLK ISLAND; PEDIGREE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION SITE;

ESR1; HAPLOTYPE ANALYSIS; HORMONE RECEPTOR GENES; MIGRAINE; PGR;

ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MELANESIA; MIGRAINE DISORDERS; PEDIGREE; POLYMORPHISM, GENETIC;

EID: 84884995867     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102413486321     Document Type: Article

References (32)

1. The International Classification of Headache Disorders. 2nd ed. Cephalalgia 2004; 24(Suppl 1): 9-160.
2. Eikermann-Haerter K, Ayata C. Cortical spreading depression and migraine. Curr Neurol Neurosci Rep. 2010 ; 10: 167-173
3. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001 ; 41: 646-657
4. Schurks M, Rist PM, Kurth T. Sex hormone receptor gene polymorphisms and migraine: A systematic review and meta-analysis. Cephalalgia. 2010 ; 30: 1306-1328
5. Colson NJ, Lea RA, Quinlan S, et al. Investigation of hormone receptor genes in migraine. Neurogenetics. 2005 ; 6: 17-23
6. Martin VT, Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis - part I. Headache. 2006 ; 46: 3-23
7. Martin VT, Behbehani M. Ovarian hormones and migraine headache: Understanding mechanisms and pathogenesis - part 2. Headache. 2006 ; 46: 365-386
8. Martin VT, Lipton RB. Epidemiology and biology of menstrual migraine. Headache. 2008 ; 48: S124 - S130
9. Serva WA, Serva VM, de Fátima Costa Caminha M, et al. Course of migraine during pregnancy among migraine sufferers before pregnancy. Arq Neuropsiquiatr. 2011 ; 69: 613-619
10. Nilsson S, Makela S, Treuter E, et al. Mechanisms of estrogen action. Physiol Rev. 2001 ; 81: 1535-1565
11. Levin ER. Cell localization, physiology, and nongenomic actions of estrogen receptors. J Appl Physiol. 2001 ; 91: 1860-1867
12. Osterlund MK, Hurd YL. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol. 2001 ; 64: 251-267
13. Bethea CL, Lu NZ, Gundlah C, et al. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol. 2002 ; 23: 41-100
14. Cox HC, Lea RA, Bellis C, et al. Heritability and genome-wide linkage analysis of migraine in the genetic isolate of Norfolk Island. Gene. 2012 ; 494: 119-123
15. Norfolk Island: A revised and enlarged history 1774-1998. 1774 -1998, 5th edn. Rockhampton: Central Queensland University Press, 1999. Rockhampton: Central Queensland University Press ; 1999 :
16. Bellis C, Hughes RM, Begley KN, et al. Phenotypical characterisation of the isolated Norfolk Island population focusing on epidemiological indicators of cardiovascular disease. Hum Hered. 2005 ; 60: 211-219
17. Hein R, Maranian M, Hopper JL, et al. Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One. 2012 ; 7: e42380 - e42380
18. Aulchenko YS, Ripke S, Isaacs A, et al. GenABEL: An R library for genome-wide association analysis. Bioinformatics. 2007 ; 23: 1294-1296
19. Gao X, Becker LC, Becker DM, et al. Avoiding the high Bonferroni penalty in genome-wide association studies. Genet Epidemiol. 2010 ; 34: 100-105
20. Colson NJ, Lea RA, Quinlan S, et al. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics. 2004 ; 5: 129-133
21. Oterino A, Pascual J, Ruiz de Alegría C, et al. Association of migraine and ESR1 G325C polymorphism. Neuroreport. 2006 ; 17: 61-64
22. Oterino A, Toriello M, Cayon A, et al. Multilocus analyses reveal involvement of the ESR1, ESR2, and FSHR genes in migraine. Headache. 2008 ; 48: 1438-1450
23. Joshi G, Pradhan S, Mittal B. Role of the oestrogen receptor (ESR1 PvuII and ESR1 325 C->G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population. Cephalalgia. 2010 ; 30: 311-320
24. Kaunisto MA, Kallela M, Hamalainen E, et al. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia. 2006 ; 26: 1462-1472
25. Xie H, Sun M, Liao XB, et al. Estrogen receptor alpha36 mediates a bone-sparing effect of 17beta-estrodiol in postmenopausal women. J Bone Miner Res. 2011 ; 26: 156-168
26. Dunbier AK, Anderson H, Ghazoui Z, et al. ESR1 is co-expressed with closely adjacent uncharacterised genes spanning a breast cancer susceptibility locus at 6q25.1. PLoS Genet. 2011 ; 7: e1001382 - e1001382
27. Gros-Louis F, Dupré N, Dion P, et al. Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia. Nat Genet. 2007 ; 39: 80-85
28. Bennett V. Spectrin-based membrane skeleton: A multipotential adaptor between plasma membrane and cytoplasm. Physiol Rev. 1990 ; 70: 1029-1065
29. Green EK, Grozeva D, Forty L, et al. Association at SYNE1 in both bipolar disorder and recurrent major depression. Mol Psychiatry. Epub ahead of print 8 May 2012. DOI: 10.1038/mp.2012.48.
30. Doherty JA, Rossing MA, Cushing-Haugen KL, et al. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: An Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers Prev. 2010 ; 19: 245-250
31. Scher AI, Bigal ME, Lipton RB. Comorbidity of migraine. Curr Opin Neurol. 2005 ; 18: 305-310
32. Rowe SM, Coughlan SJ, McKenna NJ, et al. Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Res. 1995 ; 55: 2743-2745